DHS 75.57 History History: CR 20-047: cr. Register October 2021 No. 790, eff. 10-1-22; correction in (2) made under s. 35.17, Stats., Register October 2021 No. 790.

DHS 75.58 DHS 75.58 Residential intoxication monitoring service.

DHS 75.58(1) (1) Service description. In this section, “residential intoxication monitoring service” means a residential service that provides 24-hour observation to monitor the safe resolution of alcohol or sedative intoxication and to monitor for the development of alcohol withdrawal for intoxicated patients who are not in need of emergency medical or behavioral healthcare. Residential intoxication monitoring services may include screening, assessment, intake, evaluation and diagnosis, observation and monitoring, case management, drug testing, counseling, individual therapy, group therapy, family therapy, psychoeducation, peer support services, recovery coaching, and recovery support services.

DHS 75.58(2) (2) Observation and medication requirements.

DHS 75.58(2)(a) (a) Observation. Trained staff shall observe a patient and record the patient’s condition at intervals no greater than every 30 minutes during the first 12 hours following admission.

DHS 75.58(2)(b) (b) Medications.

DHS 75.58(2)(b)1. 1. A residential intoxication monitoring service shall not administer or dispense medications.

DHS 75.58(2)(b)2. 2. When a patient has been admitted with prescribed medication, staff shall consult with the patient’s physician or other person licensed to prescribe and administer medications to determine the appropriateness of the patient’s continued use of the medication while under the influence of alcohol or sedatives.

DHS 75.58(2)(b)3. 3. If approval for continued use of prescribed medication is received from a prescriber, the patient may self-administer the medication under the observation of service staff.

DHS 75.58(3) (3) Prohibited admissions. No person may be admitted if any of the following apply:

DHS 75.58(3)(a) (a) The person’s behavior is determined by the service to be dangerous to self or others.

DHS 75.58(3)(b) (b) The person requires professional nursing or medical care.

DHS 75.58(3)(c) (c) The person is incapacitated by alcohol and is placed in or is determined to be in need of protective custody by a law enforcement officer as required under s. 51.45 (11) (b), Stats.

DHS 75.58(3)(d) (d) The person is under the influence of any substance other than alcohol or a sedative.

DHS 75.58(3)(e) (e) The person requires restraints.

DHS 75.58(3)(f) (f) The person requires medication normally used for the detoxification process.

DHS 75.58 History History: CR 20-047: cr. Register October 2021 No. 790, eff. 10-1-22; (2) (a) (title) created under s. 13.92 (4) (b) 2., Stats., and correction in (2) (b) 3. made under s. 35.17, Stats., Register October 2021 No. 790.

subch. VII of ch. DHS 75 Subchapter VII — Opioid Treatment Programs and Office-Based Opioid Treatment

DHS 75.59 DHS 75.59 Opioid treatment program.

DHS 75.59(1) (1) Service description. In this section, “opioid treatment program,” or “OTP,” means a service that provides for the management and rehabilitation of persons with an opioid use disorder through the use of methadone and other FDA-approved medications for the treatment of persons with an opioid use disorder, and also provides a broad range of medical and psychological services, substance use counseling and social services. OTPs shall provide adequate medical, counseling, vocational, educational, and other assessment and treatment services. These services must be available at the primary facility, except where the program sponsor has entered into a formal, documented agreement with a private or public agency, organization, practitioner, or institution to provide these services to patients enrolled in the OTP. The program sponsor, in any event, must be able to document that these services are fully and reasonably available to patients. An OTP is subject to the oversight of the SOTA.

DHS 75.59(2) (2) Requirements. To receive certification from the department under this chapter, an OTP shall comply with all requirements included in subch. IV, as applicable, be certified under and follow all requirements included in s. DHS 75.50, and the requirements of this section. If a requirement in this section conflicts with an applicable requirement in subch. IV or s. DHS 75.50, the requirement in this section shall be followed.

DHS 75.59(3) (3) Definitions. In this section:

DHS 75.59(3)(a) (a) “Biochemical monitoring” means the collection and analysis of specimens of body fluids such as blood or urine to determine use of licit or illicit drugs.

DHS 75.59(3)(b) (b) “Central registry” means an organization that obtains patient identifying information from 2 or more OTPs about individuals applying for maintenance treatment or detoxification treatment for the purpose of preventing an individual’s concurrent enrollment in more than one program.

DHS 75.59(3)(c) (c) “Clinical probation” means the period of time determined by the treatment team that a patient is required to increase frequency of service attendance due to rule violations.

DHS 75.59(3)(d) (d) “Guest dose” means administration of a medication used for the treatment of opioid addiction to a person who is not a client of the program that is administering or dispensing the medication.

DHS 75.59(3)(e) (e) “Initial dosing” means the first administration of methadone or other FDA-approved medication for the treatment of opioid use disorder to relieve a degree of withdrawal and drug craving of the patient.

DHS 75.59(3)(f) (f) “Maintenance treatment” means the dispensing of a narcotic drug in the treatment of an individual for opioid dependence.

DHS 75.59(3)(g) (g) “Mandatory schedule” means the required dosing schedule for a patient and the established frequency that the patient must attend the service.